VALUATION - Real-Options Valuation for a Biotechnology Company - Presented is a comparison of the market value of a company with the sum of the real-options values of its projects
Year of publication: |
2000
|
---|---|
Authors: | Kellogg, David ; Charnes, John M. |
Published in: |
Financial analysts' journal : FAJ. - Charlottesville, Va : CFA Institute, ISSN 0015-198X, ZDB-ID 2194090. - Vol. 56.2000, 3, p. 76-84
|
Saved in:
Saved in favorites
Similar items by person
-
MEASURING HEDGE EFFECTIVENESS FOR FAS 133 COMPLIANCE
Charnes, John M., (2003)
-
Real Options Volatility Estimation with Correlated Inputs
Cobb, Barry R., (2004)
-
Multistage Monte Carlo Method for Solving Influence Diagrams Using Local Computation
Charnes, John M., (2004)
- More ...